Synthetic biology platform programming patient-derived stem cells into cell types

CEO & Co-Founder

Co-Founder and Chief Innovation Officer

Sanofi to lay off 229 Blueprint Medicines staffers, close Cambridge offices following acquisition

STAT+: Up and down the ladder: The latest comings and goings

GC Therapeutics Appoints Stem Cell Therapy Leader Stefan Irion, MD, as Chief Scientific Officer

GC Therapeutics Appoints Kate Haviland as Board Chair and Provides Corporate Update

Machine Learning Researcher

GC Therapeutics is a genome-wide cell landscape exploration company using an integrated synthetic biology and AI-driven platform for cell programming. The Machine Learning Researcher will design, train, and benchmark virtual cell models for the company’s in silico discovery platform, process multimodal biological datasets, and collaborate with experimental biologists to validate model predictions and develop therapeutic hypotheses.